Belmouhand, Mohamed http://orcid.org/0000-0001-5855-4733
Eckmann-Hansen, Christina
Ilginis, Tomas
Leinøe, Eva Birgitte
Mortensen, Bo Kok
Larsen, Michael
Funding for this research was provided by:
Rigshospitalet (E-23334-02)
Helsefonden (19-B-0063)
Aase og Ejnar Danielsens Fond (18-10-0698)
Beckett-Fonden (19-2-3490)
Einar Willumsen Foundation (500028)
P. Carl Petersens Fond (19102)
H2020 European Research Council (780989)
Article History
Received: 1 February 2021
Accepted: 29 June 2021
First Online: 13 July 2021
Declarations
:
: Ethics approval was not necessary for this case report.
: Both study participants gave their oral and written informed consent for publication.
: ML has consulted, spoken or been a trial investigator for Novartis, Chiesi, Allergan, Bayer, Alcon, AbbVie, Biogen, Novo Nordisk, Eli Lilly, Spark Therapeutics, Nightstar, Sanofi and Roche.